Selected research
Industry Growth & Trends
Global Vaccine Testing Service Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Vaccine Testing Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Vaccine Testing Service is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Vaccine Testing Service is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Vaccine Testing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Vaccine Testing Service market include RSSL, Labcorp Drug Development, Charles River Laboratories, PPD, WuXi Biologics, Valneva, IQVIA Laboratories Vaccines, Minaris Advanced Testing and IntoxLab, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Vaccine Testing Service market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Vaccine Testing Service market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Vaccine Testing Service market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Vaccine Testing Service.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Vaccine Testing Service market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Vaccine Testing Service Market by Company
RSSL
Labcorp Drug Development
Charles River Laboratories
PPD
WuXi Biologics
Valneva
IQVIA Laboratories Vaccines
Minaris Advanced Testing
IntoxLab
Creative Diagnostics
Vaccine Testing Service Segment by Type
Physical and Chemical Testing
Microbial Detection
Immunological Testing
Others
Vaccine Testing Service Segment by Application
Inactivated Vaccine
Subunit Vaccine
Toxoid Vaccine
mRNA Vaccine
Viral Vector Vaccine
Others
Vaccine Testing Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Vaccine Testing Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Vaccine Testing Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Vaccine Testing Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Vaccine Testing Service companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Physical and Chemical Testing
- Microbial Detection
- Immunological Testing
- Others
Applications
- Inactivated Vaccine
- Subunit Vaccine
- Toxoid Vaccine
- mRNA Vaccine
- Viral Vector Vaccine
- Others
Companies covered
- RSSL
- Labcorp Drug Development
- Charles River Laboratories
- PPD
- WuXi Biologics
- Valneva
- IQVIA Laboratories Vaccines
- Minaris Advanced Testing
- IntoxLab
- Creative Diagnostics
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Vaccine Testing Service Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Vaccine Testing Service Market Size by Region (2021-2032)
- 1.4.1 Global Vaccine Testing Service Market Size by Region (2021-2026)
- 1.4.2 Global Vaccine Testing Service Market Size by Region (2027-2032)
- 1.5 Key Regions Vaccine Testing Service Market Size (2021-2032)
- 1.5.1 North America Vaccine Testing Service Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Vaccine Testing Service Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Vaccine Testing Service Market Size Growth Rate (2021-2032)
- 1.5.4 South America Vaccine Testing Service Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Vaccine Testing Service Market Size Growth Rate (2021-2032)
2 Vaccine Testing Service Market by Type
- 2.1 Type Introduction
- 2.1.1 Physical and Chemical Testing
- 2.1.2 Microbial Detection
- 2.1.3 Immunological Testing
- 2.1.4 Others
- 2.2 Global Vaccine Testing Service Market Size by Type
- 2.2.1 Global Vaccine Testing Service Market Size Overview by Type (2021-2032)
- 2.2.2 Global Vaccine Testing Service Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Vaccine Testing Service Market Size Forecasted by Type (2027-2032)
- 2.3 Global Vaccine Testing Service Market Size by Regions
- 2.3.1 North America Vaccine Testing Service Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Vaccine Testing Service Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Vaccine Testing Service Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Vaccine Testing Service Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Vaccine Testing Service Market Size Breakdown by Type (2021-2026)
3 Vaccine Testing Service Market by Application
- 3.1 Type Introduction
- 3.1.1 Inactivated Vaccine
- 3.1.2 Subunit Vaccine
- 3.1.3 Toxoid Vaccine
- 3.1.4 mRNA Vaccine
- 3.1.5 Viral Vector Vaccine
- 3.1.6 Others
- 3.2 Global Vaccine Testing Service Market Size by Application
- 3.2.1 Global Vaccine Testing Service Market Size Overview by Application (2021-2032)
- 3.2.2 Global Vaccine Testing Service Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Vaccine Testing Service Market Size Forecasted by Application (2027-2032)
- 3.3 Global Vaccine Testing Service Market Size by Regions
- 3.3.1 North America Vaccine Testing Service Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Vaccine Testing Service Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Vaccine Testing Service Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Vaccine Testing Service Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Vaccine Testing Service Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Vaccine Testing Service Industry Trends
- 4.2 Vaccine Testing Service Industry Drivers
- 4.3 Vaccine Testing Service Industry Opportunities and Challenges
- 4.4 Vaccine Testing Service Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Vaccine Testing Service Revenue (2021-2026)
- 5.2 Global Vaccine Testing Service Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Vaccine Testing Service Key Company Headquarters & Area Served
- 5.4 Global Vaccine Testing Service Company, Product Type & Application
- 5.5 Global Vaccine Testing Service Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Vaccine Testing Service Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Vaccine Testing Service Players Market Share by Revenue in 2025
- 5.6.3 2025 Vaccine Testing Service Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 RSSL
- 6.1.1 RSSL Company Information
- 6.1.2 RSSL Business Overview
- 6.1.3 RSSL Vaccine Testing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 RSSL Vaccine Testing Service Product Portfolio
- 6.1.5 RSSL Recent Developments
- 6.2 Labcorp Drug Development
- 6.2.1 Labcorp Drug Development Company Information
- 6.2.2 Labcorp Drug Development Business Overview
- 6.2.3 Labcorp Drug Development Vaccine Testing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Labcorp Drug Development Vaccine Testing Service Product Portfolio
- 6.2.5 Labcorp Drug Development Recent Developments
- 6.3 Charles River Laboratories
- 6.3.1 Charles River Laboratories Company Information
- 6.3.2 Charles River Laboratories Business Overview
- 6.3.3 Charles River Laboratories Vaccine Testing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Charles River Laboratories Vaccine Testing Service Product Portfolio
- 6.3.5 Charles River Laboratories Recent Developments
- 6.4 PPD
- 6.4.1 PPD Company Information
- 6.4.2 PPD Business Overview
- 6.4.3 PPD Vaccine Testing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 PPD Vaccine Testing Service Product Portfolio
- 6.4.5 PPD Recent Developments
- 6.5 WuXi Biologics
- 6.5.1 WuXi Biologics Company Information
- 6.5.2 WuXi Biologics Business Overview
- 6.5.3 WuXi Biologics Vaccine Testing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 WuXi Biologics Vaccine Testing Service Product Portfolio
- 6.5.5 WuXi Biologics Recent Developments
- 6.6 Valneva
- 6.6.1 Valneva Company Information
- 6.6.2 Valneva Business Overview
- 6.6.3 Valneva Vaccine Testing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Valneva Vaccine Testing Service Product Portfolio
- 6.6.5 Valneva Recent Developments
- 6.7 IQVIA Laboratories Vaccines
- 6.7.1 IQVIA Laboratories Vaccines Company Information
- 6.7.2 IQVIA Laboratories Vaccines Business Overview
- 6.7.3 IQVIA Laboratories Vaccines Vaccine Testing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 IQVIA Laboratories Vaccines Vaccine Testing Service Product Portfolio
- 6.7.5 IQVIA Laboratories Vaccines Recent Developments
- 6.8 Minaris Advanced Testing
- 6.8.1 Minaris Advanced Testing Company Information
- 6.8.2 Minaris Advanced Testing Business Overview
- 6.8.3 Minaris Advanced Testing Vaccine Testing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Minaris Advanced Testing Vaccine Testing Service Product Portfolio
- 6.8.5 Minaris Advanced Testing Recent Developments
- 6.9 IntoxLab
- 6.9.1 IntoxLab Company Information
- 6.9.2 IntoxLab Business Overview
- 6.9.3 IntoxLab Vaccine Testing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 IntoxLab Vaccine Testing Service Product Portfolio
- 6.9.5 IntoxLab Recent Developments
- 6.10 Creative Diagnostics
- 6.10.1 Creative Diagnostics Company Information
- 6.10.2 Creative Diagnostics Business Overview
- 6.10.3 Creative Diagnostics Vaccine Testing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Creative Diagnostics Vaccine Testing Service Product Portfolio
- 6.10.5 Creative Diagnostics Recent Developments
7 North America
- 7.1 North America Vaccine Testing Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Vaccine Testing Service Market Size by Country (2021-2026)
- 7.3 North America Vaccine Testing Service Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Vaccine Testing Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Vaccine Testing Service Market Size by Country (2021-2026)
- 8.3 Europe Vaccine Testing Service Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Vaccine Testing Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Vaccine Testing Service Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Vaccine Testing Service Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Vaccine Testing Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Vaccine Testing Service Market Size by Country (2021-2026)
- 10.3 South America Vaccine Testing Service Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Vaccine Testing Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Vaccine Testing Service Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Vaccine Testing Service Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst